Novartis Ag (NVSEF) Other Non Operating Income (2009 - 2026)

Novartis Ag (NVSEF) has 15 years of Other Non Operating Income data on file, last reported at -$50.0 million in Q1 2026.

• Quarterly Other Non Operating Income fell 394.12% year-over-year to -$50.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$203.0 million (down 234.44% YoY) and the FY2025 annual result came in at -$136.0 million, down 197.14% from the prior year.
• Other Non Operating Income improved to -$50.0 million in Q1 2026 per NVSEF's latest filing, from -$92.0 million in the prior quarter.
• The five-year high for Other Non Operating Income was $104.0 million in Q1 2023, with the low at -$92.0 million in Q4 2025.
• Average Other Non Operating Income over 5 years is $12.2 million, with a median of $17.0 million recorded in 2025.
• Year-over-year, Other Non Operating Income jumped 431.25% in 2023 and plunged 394.12% in 2026.
• Novartis Ag's Other Non Operating Income stood at $24.0 million in 2022, then decreased by 25.0% to $18.0 million in 2023, then soared by 83.33% to $33.0 million in 2024, then tumbled by 378.79% to -$92.0 million in 2025, then soared by 45.65% to -$50.0 million in 2026.
• Business Quant data shows NVSEF's Other Non Operating Income at -$50.0 million in Q1 2026, -$92.0 million in Q4 2025, and -$20.0 million in Q3 2025.